Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 35 Carcinoma, Hepatocellular 17 Neoplasm Metastasis 15 Prostatic Neoplasms 13 Neoplasms 9 Neuroendocrine Tumors 7 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 6 Brain Neoplasms 6 Sarcoma, Ewing 5 Sarcoma 5 Osteosarcoma 5 Kidney Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Transitional Cell 5 Recurrence 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Clear-cell metastatic renal cell carcinoma 4 Urinary Bladder Neoplasms 3 Lung Neoplasms 3 Carcinoid Tumor 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Thyroid Diseases 2 Pheochromocytoma 2 Paraganglioma 2 Neurofibroma, Plexiform 2 Melanoma 2

Interventions

pembrolizumab 1 niraparib 1 durvalumab 1 cabozantinib 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urothelial Cancer × cabozantinib × Clear all

NCT03425201 2024-12-31

NICARAGUA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1/2 Completed

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡